(Q40416329)

20 September 2017

title

P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy (English)

1 reference

20 September 2017

1 reference

1 reference

Stefan Oberndorfer

1

1 reference

20 September 2017

Maria Piribauer

2

1 reference

20 September 2017

Christine Marosi

3

1 reference

20 September 2017

Heinz Lahrmann

4

1 reference

20 September 2017

Peter Hitzenberger

5

1 reference

20 September 2017

Wolfgang Grisold

6

1 reference

20 September 2017

publication date

1 May 2005

1 reference

Journal of Neuro-Oncology

20 September 2017

published in

1 reference

20 September 2017

volume

72

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

255-260

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-004-2338-2

20 September 2017

exact match

0 references

cites work

The course of seizure disorders in patients with malignant gliomas.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-004-2338-2

The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-004-2338-2

Prolonged depression of hepatic microsomal drug metabolism and hemoprotein levels following a single dose of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)

21 January 2018

1 reference

12 December 2020

Prevalence and prognostic significance of epilepsy in patients with gliomas.

1 reference

12 December 2020

Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors

1 reference

12 December 2020

Interaction between phenytoin and valproic acid: plasma protein binding and metabolic effects

1 reference

12 December 2020

Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastoma

1 reference

12 December 2020

Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation

1 reference

12 December 2020

Interactions between antiepileptic and chemotherapeutic drugs

1 reference

12 December 2020

The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the pl

1 reference

12 December 2020

Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System Consortium

1 reference

12 December 2020

The importance of drug interactions in epilepsy therapy

1 reference

12 December 2020

A prospective study on glioblastoma in the elderly

1 reference

12 December 2020

The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management

1 reference

12 December 2020

Studies on the mechanism of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)-induced hepatotoxicity. II. Biochemical and morphological characterization of the injury and its prevention by phenobarbital.

1 reference

12 December 2020

Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants. NABTT CNS Consortium. The New Approaches to Brain Tumor Therapy.

1 reference

12 December 2020

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma

1 reference

12 December 2020

Influence of anticonvulsants on the metabolism and elimination of irinotecan. A North American Brain Tumor Consortium preliminary report.

1 reference

12 December 2020

Chemotherapy for brain tumors

1 reference

12 December 2020

Irinotecan therapy in adults with recurrent or progressive malignant glioma.

1 reference

12 December 2020

Interaction of dexamethasone with phenytoin

1 reference

12 December 2020

CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity

1 reference

12 December 2020

Two studies evaluating irinotecan treatment for recurrent malignant glioma using an every-3-week regimen

1 reference

12 December 2020

Irinotecan in the treatment of glioma patients: current and future studies of the North Central Cancer Treatment Group

1 reference

12 December 2020

Effect of valproate on the pharmacokinetics and pharmacodynamics of lorazepam

1 reference

12 December 2020

Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors

1 reference

12 December 2020

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide

1 reference

12 December 2020

1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels

1 reference

12 December 2020

Use of phenobarbital and high doses of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the treatment of brain tumor-bearing mice

1 reference

12 December 2020

Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes

1 reference

12 December 2020

Clinical pharmacology and therapeutic use of the new antiepileptic drugs

1 reference

12 December 2020

High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.

1 reference

12 December 2020

Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs

1 reference

12 December 2020

Interaction of the oncolytic drug, 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea with the mixed-function oxidase system in rats

1 reference

12 December 2020

Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs

1 reference

12 December 2020

The role of chemotherapy in brain metastases.

1 reference

12 December 2020

Variability and clinical relevance of the interaction between sodium valproate and carbamazepine in epileptic patients

1 reference

12 December 2020

Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity

1 reference

12 December 2020

Survival of patients with recurrent malignant glioma treated with temozolomide: a retrospective observational study

1 reference

12 December 2020

Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative

1 reference

12 December 2020

[The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna].

1 reference

12 December 2020

10.1007/S11060-004-2338-2

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1042135639

0 references

1 reference